Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Kloxxado for opioid overdose

May 4, 2021

FDA clears IND for phase II trial of CT-868 in overweight and obese patients with type 2 diabetes

May 4, 2021

Vaxart reports phase I findings on oral COVID-19 vaccine VXA-CoV2-1

May 4, 2021

XBiotech and INSERM collaborate on phase II/III trial of XB-2001

May 4, 2021

LRRK2 inhibitor DNL-151 well tolerated in healthy volunteers and patients with PD

May 4, 2021

Mitochondrial peptide causes septic shock nosocomials, mortality

May 4, 2021

Administration of 5,6-DiHETE, an endogenous TRPV4 antagonist, contributes to colitis healing in mice

May 4, 2021

Discovery and optimization of novel N-pyrimidines as IDO1 inhibitors

May 4, 2021

DF-6002 shows robust antitumor activity in preclinical models

May 4, 2021

HORNBILL phase I data reported for BI-764524

May 4, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...